Eli Lilly and Company
LARTRUVO
Manufacturer:
Eli Lilly and Company
Name:
LARTRUVO
HCPCS Code Descriptor:
Injection, olaratumab, 10 mg
Category:
J Code
HCPCS:
J9285
NDC(s):
00002-8926-01, 00002-7190-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
LARTRUVO is an Oncology drug manufactured by Eli Lilly and Company and administered via the Intravenous route of administration. The J Code: J9285 is aligned to the drug LARTRUVO.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/18
HCPCS Effective Date:
1/1/23
HCPCS Short Description:
Inj, olaratumab, 10 mg
Billing and Coding Guide:
Not Found
Patient Assistance:
Not Found
